Page 4 of 5 · 112 questions tagged lipids.
The case in front of me: magnesium · TSH · dulaglutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
Stated plainly: ALT · eight weeks · survodutide. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not discarded…
The case in front of me: GGT · four weeks · retatrutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to…
Details up front: TSH · magnesium · liraglutide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
The specifics, since they change the answer: triglycerides · ten weeks · a GLP-1 receptor agonist. Something has gone wrong and I would like to know how badly before…
The particulars: triglycerides · ten weeks · mazdutide. Something has gone wrong and I would like to know how badly before I decide what to do. Nothing else in the…
What I have: eGFR · HbA1c · tirzepatide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible…
I have the full paper rather than the abstract, and the supplementary appendix. I have the document in front of me and I can read the numbers. What I cannot do is…
The specifics, since they change the answer: triglycerides · ten weeks · cagrilintide. Something has gone wrong and I would like to know how badly before I decide…
The case in front of me: HbA1c · twelve weeks · dulaglutide. I have two candidate explanations and no way to distinguish them. The same procedure has worked without…
Conditions: magnesium · TSH · orforglipron. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I…
What I am working with: LDL-C · eight weeks · survodutide. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not…
The clinician who ordered the panel was not concerned; I would still like to understand it. The figures are clear enough; the question is what they mean and what they…
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
Details up front: eGFR · six weeks · oral semaglutide. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the…
What I am working with: lipase · two weeks · ecnoglutide. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
Conditions: HbA1c · eGFR · retatrutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I can…
Concretely: HbA1c · twelve weeks · retatrutide. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident…
Numbers first: ApoB · ferritin · tirzepatide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
I have the full paper rather than the abstract, and the supplementary appendix. I have the document in front of me and I can read the numbers. What I cannot do is…
The specifics, since they change the answer: cystatin C · three weeks · cagrilintide. An unexpected observation, and I would like a differential rather than…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I would like help reading this properly rather than being…
The clinician who ordered the panel was not concerned; I would still like to understand it. I would like to know the limits of what can be inferred from this. What I…
Numbers first: albumin-to-creatinine ratio · sixteen weeks · oral semaglutide. I have a result I cannot explain, and I would rather diagnose it than guess. I have…